| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-07 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-05 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.18 | 7e-05 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |